COGT Operating Cash Flow (Statement)
Cogent Biosciences Inc · Operating Cash Flow (Statement)
COGT Operating Cash Flow (Statement)
Latest reported-$307.55Mperiod ending
COGT Cash from Operations ($17.72M → -$307.55M)
Annual operating cash flow (statement)
High-resolution chart · PNG
COGT operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -264,444,000 | |
| -207,791,000 | |
| -153,624,000 | |
| -118,638,000 | |
| -58,763,000 | |
| -35,850,000 | |
| -41,514,000 | |
| -32,489,000 | |
| -25,835,000 | |
| -18,640,000 | |
| 17,716,000 |